{"id":"https://openalex.org/W4206643763","doi":"https://doi.org/10.1016/j.apsb.2021.12.017","title":"NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion","display_name":"NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-30","ids":{"openalex":"https://openalex.org/W4206643763","doi":"https://doi.org/10.1016/j.apsb.2021.12.017","pmid":"https://pubmed.ncbi.nlm.nih.gov/35755293","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9214341"},"language":"en","primary_location":{"id":"doi:10.1016/j.apsb.2021.12.017","doi":"https://doi.org/10.1016/j.apsb.2021.12.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2021.12.017","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4206643763"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.apsb.2021.12.017","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021315052","display_name":"Ying Wu","orcid":"https://orcid.org/0000-0002-6288-4636","observed_orcids":["https://orcid.org/0000-0002-6288-4636"]},"institutions":[{"id":"https://openalex.org/I177933477","display_name":"Second Military Medical University","ror":"https://ror.org/04tavpn47","country_code":"CN","type":"education","lineage":["https://openalex.org/I177933477"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ying Wu","raw_affiliation_strings":["School of Pharmacy, Second Military Medical University, Shanghai 200433, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Second Military Medical University, Shanghai 200433, China","institution_ids":["https://openalex.org/I177933477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025623995","display_name":"Congying Pu","orcid":"https://orcid.org/0009-0008-0635-6223","observed_orcids":["https://orcid.org/0009-0008-0635-6223"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"id":"https://openalex.org/I4210165038","display_name":"University of Chinese Academy of Sciences","ror":"https://ror.org/05qbk4x57","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210165038"]},{"id":"https://openalex.org/I4391767758","display_name":"State Key Laboratory of Drug Research","ror":"https://ror.org/058t7w767","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4391767758"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Congying Pu","raw_affiliation_strings":["State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4210165038","https://openalex.org/I4391767758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083140508","display_name":"Yixian Fu","orcid":"https://orcid.org/0000-0002-5094-8874","observed_orcids":["https://orcid.org/0000-0002-5094-8874"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"id":"https://openalex.org/I4210165038","display_name":"University of Chinese Academy of Sciences","ror":"https://ror.org/05qbk4x57","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210165038"]},{"id":"https://openalex.org/I4391767758","display_name":"State Key Laboratory of Drug Research","ror":"https://ror.org/058t7w767","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4391767758"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yixian Fu","raw_affiliation_strings":["State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4210165038","https://openalex.org/I4391767758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082494084","display_name":"Guoqiang Dong","orcid":"https://orcid.org/0000-0003-1708-7803","observed_orcids":["https://orcid.org/0000-0003-1708-7803"]},"institutions":[{"id":"https://openalex.org/I177933477","display_name":"Second Military Medical University","ror":"https://ror.org/04tavpn47","country_code":"CN","type":"education","lineage":["https://openalex.org/I177933477"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Guoqiang Dong","raw_affiliation_strings":["School of Pharmacy, Second Military Medical University, Shanghai 200433, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Second Military Medical University, Shanghai 200433, China","institution_ids":["https://openalex.org/I177933477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100712730","display_name":"Min Huang","orcid":"https://orcid.org/0000-0001-6735-1612","observed_orcids":["https://orcid.org/0000-0001-6735-1612"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"id":"https://openalex.org/I4210165038","display_name":"University of Chinese Academy of Sciences","ror":"https://ror.org/05qbk4x57","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210165038"]},{"id":"https://openalex.org/I4391767758","display_name":"State Key Laboratory of Drug Research","ror":"https://ror.org/058t7w767","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4391767758"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Min Huang","raw_affiliation_strings":["State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China"],"raw_orcid":"https://orcid.org/0000-0001-6735-1612","affiliations":[{"raw_affiliation_string":"State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4210165038","https://openalex.org/I4391767758"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057853505","display_name":"Chunquan Sheng","orcid":"https://orcid.org/0000-0001-9489-804X","observed_orcids":["https://orcid.org/0000-0001-9489-804X"]},"institutions":[{"id":"https://openalex.org/I177933477","display_name":"Second Military Medical University","ror":"https://ror.org/04tavpn47","country_code":"CN","type":"education","lineage":["https://openalex.org/I177933477"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Chunquan Sheng","raw_affiliation_strings":["School of Pharmacy, Second Military Medical University, Shanghai 200433, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Second Military Medical University, Shanghai 200433, China","institution_ids":["https://openalex.org/I177933477"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5057853505","https://openalex.org/A5082494084","https://openalex.org/A5100712730"],"corresponding_institution_ids":["https://openalex.org/I177933477","https://openalex.org/I19820366","https://openalex.org/I4210112820","https://openalex.org/I4210165038","https://openalex.org/I4391767758"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":{"value":2600,"currency":"USD","value_usd":2600},"fwci":3.2418,"has_fulltext":true,"cited_by_count":97,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94925508,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"12","issue":"6","first_page":"2859","last_page":"2868"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.7020999789237976,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.7020999789237976,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.1348000019788742,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.04149999842047691,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/visfatin","display_name":"visfatin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.7429999709129333},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.9049999713897705},{"id":"https://openalex.org/keywords/extracellular-nampt","display_name":"extracellular NAMPT","score":0.8920000195503235},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-degradation","display_name":"ubiquitin-proteasome degradation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.8830000162124634},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7000129818916321},{"id":"https://openalex.org/C2780391879","wikidata":"https://www.wikidata.org/wiki/Q18035058","display_name":"Nicotinamide phosphoribosyltransferase","level":4,"score":0.6546985507011414},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5108323097229004},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5088484287261963},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44840008020401},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.44072359800338745},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4400591552257538},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42030471563339233},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3392946720123291},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.31303882598876953},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2891036868095398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19800102710723877},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1095876395702362},{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.08935767412185669},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.08507198095321655}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.apsb.2021.12.017","doi":"https://doi.org/10.1016/j.apsb.2021.12.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2021.12.017","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9214341","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9214341/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9214341/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharm Sin B","raw_type":"Text"},{"id":"pmid:35755293","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35755293","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Sinica. B","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:319f1f2f2d1b440ea7cd769ccfeee7fc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/319f1f2f2d1b440ea7cd769ccfeee7fc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Pharmaceutica Sinica B, Vol 12, Iss 6, Pp 2859-2868 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.apsb.2021.12.017","doi":"https://doi.org/10.1016/j.apsb.2021.12.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.apsb.2021.12.017","pdf_url":null,"source":{"id":"https://openalex.org/S2736993989","display_name":"Acta Pharmaceutica Sinica B","issn_l":"2211-3835","issn":["2211-3835","2211-3843"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica Sinica B","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2207742060","display_name":null,"funder_award_id":"91957126","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G6519793249","display_name":null,"funder_award_id":"82030105","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G8695913326","display_name":null,"funder_award_id":"2020YFA0509100","funder_id":"https://openalex.org/F4320335777","funder_display_name":"National Key Research and Development Program of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320335777","display_name":"National Key Research and Development Program of China","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4206643763.pdf","grobid_xml":"https://content.openalex.org/works/W4206643763.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1985482335","https://openalex.org/W2013989636","https://openalex.org/W2025750169","https://openalex.org/W2031050244","https://openalex.org/W2044982247","https://openalex.org/W2049801905","https://openalex.org/W2095566224","https://openalex.org/W2104532843","https://openalex.org/W2108536847","https://openalex.org/W2133067616","https://openalex.org/W2267891632","https://openalex.org/W2269150585","https://openalex.org/W2327334027","https://openalex.org/W2343462384","https://openalex.org/W2409568753","https://openalex.org/W2572397812","https://openalex.org/W2596093424","https://openalex.org/W2737947328","https://openalex.org/W2742495099","https://openalex.org/W2775486301","https://openalex.org/W2794225798","https://openalex.org/W2806694687","https://openalex.org/W2906814157","https://openalex.org/W2920804157","https://openalex.org/W2997890859","https://openalex.org/W3004448724","https://openalex.org/W3007150976","https://openalex.org/W3023706389","https://openalex.org/W3025899813","https://openalex.org/W3092380639","https://openalex.org/W3102558410","https://openalex.org/W3160367062"],"related_works":["https://openalex.org/W4308037678","https://openalex.org/W2283582838","https://openalex.org/W2917022358","https://openalex.org/W4396766576","https://openalex.org/W7130590335","https://openalex.org/W7017360240","https://openalex.org/W4391513349","https://openalex.org/W4399855281","https://openalex.org/W4389580976"],"abstract_inverted_index":{"Nicotinamide":[0],"phosphoribosyl":[1],"transferase":[2],"(NAMPT)":[3],"is":[4,78,140,182],"considered":[5],"as":[6,80],"a":[7,64,81,196],"promising":[8],"target":[9],"for":[10,199],"cancer":[11,18],"therapy":[12],"given":[13],"its":[14,68],"critical":[15],"engagement":[16],"in":[17,98,167],"metabolism":[19],"and":[20,83,97,128,174,192],"inflammation.":[21],"However,":[22],"therapeutic":[23],"benefit":[24],"of":[25,41,55,67,86,103,110,114,137,162,165,189,202],"NAMPT":[26,47,91,105,143,166,178],"enzymatic":[27,69,144],"inhibitors":[28,145],"appears":[29],"very":[30],"limited,":[31],"likely":[32],"due":[33],"to":[34,37,142,148,184],"the":[35,53,94,101,107,111,134,150,159,169,176,186,200],"failure":[36],"intervene":[38],"non-enzymatic":[39,112],"functions":[40],"NAMPT.":[42,115],"Herein,":[43],"we":[44],"show":[45],"that":[46,146,181],"dampens":[48],"antitumor":[49,130],"immunity":[50],"by":[51],"promoting":[52],"expansion":[54],"tumor":[56,125,171],"infiltrating":[57,126],"myeloid":[58],"derived":[59],"suppressive":[60],"cells":[61],"(MDSCs)":[62],"via":[63,93],"mechanism":[65],"independent":[66],"activity.":[70],"Using":[71],"proteolysis-targeting":[72],"chimera":[73],"(PROTAC)":[74],"technology,":[75],"PROTAC":[76,119,138,179],"A7":[77,120,139,180],"identified":[79],"potent":[82],"selective":[84],"degrader":[85],"NAMPT,":[87,123],"which":[88],"degrades":[89,122],"intracellular":[90],"(iNAMPT)":[92],"ubiquitin\u2013proteasome":[95],"system,":[96],"turn":[99],"decreases":[100],"secretion":[102],"extracellular":[104],"(eNAMPT),":[106],"major":[108],"player":[109],"activity":[113,136],"In":[116],"vivo":[117],",":[118,173],"efficiently":[121],"inhibits":[124],"MDSCs,":[127],"boosts":[129],"efficacy.":[131],"Of":[132],"note,":[133],"anticancer":[135],"superior":[141],"fail":[147],"achieve":[149],"same":[151],"impact":[152],"on":[153],"MDSCs.":[154],"Together,":[155],"our":[156],"findings":[157],"uncover":[158],"new":[160,197],"role":[161],"enzymatically-independent":[163],"function":[164,188],"remodeling":[168],"immunosuppressive":[170],"microenvironment":[172],"reports":[175],"first":[177],"able":[183],"block":[185],"pro-tumor":[187],"both":[190],"iNAMPT":[191],"eNAMPT,":[193],"pointing":[194],"out":[195],"direction":[198],"development":[201],"NAMPT-targeted":[203],"therapies.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4206643763","counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":28},{"year":2024,"cited_by_count":28},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-01-25T00:00:00"}
